Rapid enrichment of cell phospholipids in long-chain polyunsaturated ω-3 fatty acids after a bolus intravenous injection of a medium-chain triacylglycerol: Fish oil emulsion in humans

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 6, 2012, Pages 671-676

  Carpentier, Yvon A ^a   Portois, Laurence ^a   Malaisse, Willy J ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

cell phospholipids; long chain polyunsaturated 3 fatty acids; medium chain triacylglycerol:fish oil emulsion

Indexed keywords

ALPHA TOCOPHEROL; CALCIUM; FATTY ACID; FISH OIL; LIPID EMULSION; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; MEDIUM CHAIN TRIACYLGLYCEROL; OMEGA 3 FATTY ACID; POTASSIUM; TRIACYLGLYCEROL;

BLOOD CELL; CELL LEVEL; FATTY ACID BLOOD LEVEL; HUMAN; LEUKOCYTE; LIPID COMPOSITION; LIPID HYDROLYSIS; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD CELLS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; FATTY LIVER; FISH OILS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PHOSPHOLIPIDS; RATS; TRIGLYCERIDES;

EID: 84867655184     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112439211     Document Type: Review

References (57)

1. Carpentier YA, Portois L, Malaisse WJ. N-E fatty acids and the metabolic syndrome. Am J Clin Nutr. 2006 ; 83: 1499S - 1504S
2. Faber J, Berkhout M, Vos AP, et al. Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses within one week in healthy men and women. J Nutr. 2011 ; 141: 964-970
3. Christensen MS, Høy C-E, Becker CC, Redgrave TG. Intestinal absorption and lymphatic transport of eicosapentaenoic (EPA), docosahexaenoic (DHA), and decanoic acids: dependence on intramolecular triacylglycerol structure. Am J Clin Nutr. 1995 ; 61: 56-61
4. Oliveira FL, Rumsey SC, Schlotzer E, Hansen I, Carpentier YA, Deckelbaum RJ. Triglyceride hydrolysis of soy oil vs fish oil emulsions. JPEN J Parenter Enteral Nutr. 1997 ; 21: 224-229
5. Carpentier YA, Portois L, Hacquebard M, Zhang J, Larondelle Y, Malaisse WJ. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. I. Intestinal phospholipids. Metab Funct Res Diabetes. 2011 ; 4: 3-9
6. Hacquebard M, Zhang J, Malaisse WJ, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. II. Relation between intestinal and hepatic phospholipids. Metab Funct Res Diabetes. 2011 ; 4: 10-13
7. Zhang J, Hacquebard M, Malaisse WJ, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. III. Liver phospholipids. Metab Funct Res Diabetes. 2011 ; 4: 14-22
8. Malaisse WJ, Hacquebard M, Zhang J, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. IV. Ratio between liver phospholipid fatty acids interconvertible in Δ-desaturase-catalyzed reactions. Metab Funct Res Diabetes. 2011 ; 4: 23-27
9. Carpentier YA, Zhang J, Hacquebard M, Malaisse WJ. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. V. Red blood cell phospholipids. Metab Funct Res Diabetes. 2011 ; 4: 28-32
10. Hacquebard M, Zhang J, Malaisse WJ, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. VI. Comparison between liver and red blood cell phospholipids. Metab Funct Res Diabetes. 2011 ; 4: 33-38
11. Carpentier YA, Hacquebard M, Zhang J, Malaisse WJ. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. VII. Brain phospholipids. Metab Funct Res Diabetes. 2011 ; 4: 39-45
12. Malaisse WJ, Zhang J, Hacquebard M, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. VIII. Comparison between liver and brain phospholipids. Metab Funct Res Diabetes. 2011 ; 4: 46-51
13. Carpentier YA, Hacquebard M, Zhang J, Malaisse WJ. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. IX. Comparison between red blood cell and brain phospholipids. Metab Funct Res Diabetes. 2011 ; 4: 52-53
14. Malaisse WJ, Zhang J, Hacquebard M, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. X. Δ-desaturase-catalyzed interconversion of fatty acids in extrahepatic sites. Metab Funct Res Diabetes. 2011 ; 4: 54-59
15. Zhang J, Hacquebard M, Larondelle Y, Malaisse WJ, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. XI. Liver triglycerides. Metab Funct Res Diabetes. 2011 ; 4: 60-66
16. Zhang J, Hacquebard M, Malaisse WJ, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. XII. Adipose tissue lipids. Metab Funct Res Diabetes. 2011 ; 4: 67-71
17. Hacquebard M, Zhang J, Portois L, Larondelle Y, Malaisse WJ, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. XIII. Body weight and food intake. Metab Funct Res Diabetes. 2011 ; 4: 72-77
18. Zhang J, Hacquebard M, Louchami K, Malaisse WJ, Carpentier YA. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. XIV. Plasma insulin and glucose, insulinogenic index and insulin resistance HOMA. Metab Funct Res Diabetes. 2011 ; 4: 78-80
19. Carpentier YA, Hacquebard M, Zhang J, Larondelle Y, Portois L, Malaisse WJ. The metabolic syndrome of ω-3-depleted rats: dietary changes in lipid fatty acid pattern without changes in total lipid content. XV. Comprehensive view. Metab Funct Res Diabetes. 2011 ; 4: 81-87
20. Waitzberg DL, Torrinhass RS. Fish oil lipid emulsions and immune response: what clinicians need to know. Nutr Clin Pract. 2009 ; 24: 487-499
21. Laviano A, Rossi Fanelli F. Lipid emulsions in parenteral nutrition: does one size fits all?. S Afr J Clin Nutr. 2010 ; 23: S08 - S10
22. Sabater J, Masclans JR, Sacanell J, Chacon P, Sabin P, Planas M. Effect of an omega-3 fatty acid-enriched lipid emulsion on eicosanoid synthesis in acute respiratory distress syndrome (ARDS): a prospective, randomized, double-blind, parallel group study. Nutr Metab (London). 2011 ; 8: 22-31
23. Jurewitsch B, Gardiner G, Naccarato M, Jeejeebhoy KN. Omega 3-enriched lipid emulsion for liver salvage in parenteral nutrition-induced cholestasis in the adult patient. JPEN J Parenter Enteral Nutr. 2011 ; 35: 386-390
24. Carpentier YA, Hacquebard M, Portois L, Dupont IE, Deckelbaum RJ, Malaisse WJ. Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium-chain triacylglycerol:fish oil emulsion in humans. Am J Clin Nutr. 2010 ; 91: 875-882
25. Carpentier YA, Hacquebard M. Intravenous lipid emulsions to deliver omega 3 fatty acids. Prostag Leukotr Ess. 2006 ; 75: 145-148
26. Carpentier YA, Dupont I, Portois L, Malaisse WJ. Preclinical investigations of a medium-chain triglyceride:fish oil emulsion, I: effects of bovine milk lipoprotein lipase on lipid composition. Int J Mol Med. 2006 ; 18: 761-773
27. Malaisse WJ, Portois L, Carpentier YA. Preclinical investigations of a medium-chain triglyceride fish oil emulsion, II: lipoprotein lipase-catalyzed hydrolysis of long-chain polyunsaturated ω-3 fatty acids. Curr Top Biotechnol. 2007 ; 3: 25-37
28. Carpentier YA, Dupont I, Portois L, Malaisse WJ. Preclinical investigations of a medium-chain triglyceride:fish oil emulsion, III: experiments in cultured endothelial cells. Int J Mol Med. 2006 ; 18: 1177-1185
29. Oguzhan B, Zhang Y, Louchami K, et al. Pancreatic islet function in ω-3 fatty acid-depleted rats: glucose metabolism and nutrient-stimulated insulin release. Endocrine. 2006 ; 29: 457-466
30. Louchami K, Zhang Y, Oguzhan B, et al. Rapid changes in liver lipid composition and pancreatic K+ handling and secretory behaviour provoked by the intravenous administration of a medium-chain triglyceride:fish oil emulsion to long-chain polyunsaturated ω-3 fatty acid-depleted rats. Int J Mol Med. 2006 ; 18: 1047-1055
31. Carpentier YA, Fontaine D, Otto A, Portois L, Fontaine J, Malaisse WJ. Sustained enrichment of liver phospholipids and triglycerides in eicosapentaenoate after a bolus intravenous injection of a medium-chain triglycerides:fish oil emulsion to streptozotocin (type 1) and Goto-Kakizaki (type 2) diabetic rats. Int J Mol Med. 2006 ; 17: 643-647
32. Oguzhan B, Sancho V, Acitores A, et al. Alteration of adipocyte metabolism in ω-3 fatty acid-depleted rats. Horm Metab Res. 2006 ; 38: 789-798
33. Carpentier YA, Peltier S, Portois L, Sebedio JL, Leverve X, Malaisse WJ. Rapid reduction of liver steatosis in rats injected with a novel lipid emulsion. Horm Metab Res. 2008 ; 40: 875-879
34. Carpentier YA, Peltier S, Portois L, Sener A, Malaisse WJ. Rapid lipid enrichment in ω-3 fatty acids: liver data. Int J Mol Med. 2008 ; 21: 367-373
35. Peltier S, Portois L, Malaisse WJ, Carpentier YA. Preferential enrichment of liver phospholipids in docosahexaenoate relative to eicosapentaenoate in ω-3-depleted rats injected with a medium-chain triglyceride:fish oil emulsion. Prostag Leukotr Ess. 2008 ; 78: 27-32
36. Portois L, Delporte C, Malaisse WJ, Carpentier YA. Fatty acid pattern of epiploic and parametrial lipids in second generation rats depleted in long-chain polyunsaturated ω-3 fatty acids. Trends Cell Mol Biol. 2007 ; 2: 55-68
37. Agascioglu E, Zhang Y, Sener A, et al. Phospholipid fatty acid pattern and D-glucose metabolism in muscles from ω-3 fatty acid-depleted rats. Biochimie. 2007 ; 89: 374-382
38. Portois L, Agascioglu E, Zhang Y, et al. Rapid effects of the intravenous injection of a medium-chain triglyceride:fish oil emulsion on the triglyceride fatty acid pattern of soleus muscle from ω-3 fatty acid-depleted rats. Horm Metab Res. 2007 ; 39: 202-206
39. Malaisse WJ, Portois L, Sener A, Carpentier YA. Perturbation and age-related changes in the fatty acid pattern of soleus muscle phospholipids and triglycerides in rats depleted in long-chain polyunsaturated ω-3 fatty acids. Int J Mol Med. 2007 ; 20: 897-904
40. Malaisse WJ, Portois L, Sener A, Carpentier YA. Brain phospholipid and triglyceride fatty acid content and pattern in rats depleted in long-chain polyunsaturated ω-3 fatty acids. Trends Cell Mol Biol. 2007 ; 2: 69-76
41. Portois L, Peltier S, Sener A, Malaisse WJ, Carpentier YA. Phospholipid and triglyceride fatty acid content and pattern in the heart of rats depleted in long-chain polyunsaturated ω-3 fatty acids. Nutr Res. 2008 ; 28: 51-57
42. Peltier S, Louchami K, Zhang Y, et al. Alteration of lipid fatty acid profile and cationic fluxes in ventricular cardiomyocytes from ω-3-depleted rats. Int J Mol Med. 2009 ; 24: 343-352
43. Delporte C, Malaisse WJ, Jurysta C, Portois L, Sener A, Carpentier YA. Altered fatty acid pattern of phospholipids and triglycerides in the submandibular gland of ω-3-depleted rats. Eur J Oral Sci. 2007 ; 115: 103-110
44. Carpentier YA, Peltier S, Portois L, et al. Accelerated clearance of plasma triglycerides and free fatty acids in ω-3-depleted rats. Horm Metab Res. 2007 ; 39: 295-305
45. Carpentier YA, Portois L, Sener A, Malaisse WJ. Age-related perturbations of plasma lipid fatty acid content and pattern in ω-3-depleted rats examined before and shortly after the intravenous injection of two distinct lipid emulsions. Trends Cell Mol Biol. 2007 ; 2: 35-53
46. Carpentier YA, Peltier S, Portois L, Sener A, Malaisse WJ. Rapid lipid enrichment in ω-3 fatty acids: plasma data. Int J Mol Med. 2008 ; 21: 355-365
47. Malaisse WJ, Portois L, Chardigny J-M, Carpentier YA. Alteration of desaturase- and elongase-catalyzed steady-state equilibrium between selected fatty acids in liver phospholipids and triglycerides of ω-3-depleted rats: comparison with plasma lipids. Res Rev Biosci. 2007 ; 1: 59-68
48. Malaisse WJ, Carpentier YA, Portois L. Phospholipid and triglyceride content in α-linolenic, eicosapentaenoic, docosapentaenoic and docosahexaenoic acid in the liver of normal and ω-3-fatty acid-depleted rats: comparison with corresponding plasma values. Res Rev Biosci. 2007 ; 1: 69-77
49. Carpentier YA, Peltier S, Portois L, Sener A, Malaisse WJ. Rapid lipid enrichment in ω-3 fatty acids: cause-to-effect relationships. Int J Mol Med. 2008 ; 21: 375-379
50. Zhang Y, Oguzhan B, Louchami K, et al. Pancreatic islet function in ω-3 fatty acid-depleted rats: alteration of calcium fluxes and calcium-dependent insulin release. Am J Physiol. 2006 ; 291: E441 - E448
51. Sener A, Zhang Y, Louchami K, et al. Alteration of K+ fluxes and insulin release in pancreatic islets from ω-3 fatty acid-depleted rats. Endocrine. 2006 ; 30: 207-211
52. Courtois P, Louchami K, Portois L, et al. Effects of a medium-chain triglyceride:fish oil emulsion administered intravenously to ω-3 fatty acid-depleted rats on cationic fluxes in aortic rings. Int J Mol Med. 2005 ; 16: 1089-1093
53. Fontaine D, Otto A, Portois L, et al. Protection of aortic endothelial function in both normal and diabetic rats by intravenous bolus injection of a medium-chain triglyceride:fish oil emulsion. Int J Mol Med. 2006 ; 18: 697-704
54. Peltier S, Malaisse WJ, Portois L, et al. Acute in vivo administration of a fish oil-containing emulsion improves post-ischemic cardiac function in ω-3-depleted rats. Int J Mol Med. 2006 ; 18: 741-749
55. Carpentier YA, Portois L, Louchami K, Zhang Y, Sener A, Malaisse WJ. Phospholipid and triacylglycerol fatty acid content and pattern in the cardiac endothelium of rats depleted in long-chain polyunsaturated ω-3 fatty acids. Cell Biochem Funct. 2008 ; 26: 33-38
56. Malaisse WJ, Hacquebard M, Carpentier YA. Fatty acid pattern of platelet and white blood cell phospholipids after intravenous injection of a medium-chain triglyceride:fish oil emulsion in normal subjects. Metab Funct Res Diabetes. 2010 ; 3: 1-6
57. Pradier O, Portois L, Malaisse WJ, Carpentier YA. Hemostatic safety of the bolus intravenous injection of a novel medium-chain triglyceride:fish oil emulsion. Int J Mol Med. 2008 ; 22: 301-307